Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

被引:9
作者
Heitel, Pascal [1 ,2 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England
[2] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany
来源
MOLECULES | 2023年 / 28卷 / 02期
关键词
heterobifunctional molecules; proximity-inducing chimeras; targeted protein modification; conditional protein degradation; INDUCED DEGRADATION; DRUG DISCOVERY; RECEPTOR; KNOCKDOWN; RECOGNITION; THERAPY; LIGANDS; PROTACS; TAG;
D O I
10.3390/molecules28020690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Posttranslational modifications (PTMs) play an important role in cell signaling and they are often deregulated in disease. This review addresses recent advances in the development of heterobifunctional small molecules that enable targeting or hijacking PTMs. This emerging field is spearheaded by proteolysis-targeting chimeras (PROTACs), that induce ubiquitination of their targets and, thus, tag them for degradation by the proteasome. Within the last decade, several improvements have been made to enhance spatiotemporal control of PROTAC-induced degradation as well as cell permeability. Inspired by the success story of PROTACs, additional concepts based on chimeric small molecules have emerged such as phosphatase-recruiting chimeras (PhoRCs). Herein, an overview of strategies causing (de-)phosphorylation, deubiquitination as well as acetylation is provided, and the opportunities and challenges of heterobifunctional molecules for drug discovery are highlighted. Although significant progress has been achieved, a plethora of PTMs have not yet been covered and PTM-inducing chimeras will be helpful tools for chemical biology and could even find application in pharmacotherapy.
引用
收藏
页数:28
相关论文
共 8 条
  • [1] Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation
    Xi, Meiyang
    Chen, Yi
    Yang, Hongyu
    Xu, Huiting
    Du, Kui
    Wu, Chunlei
    Xu, Yanfei
    Deng, Liping
    Luo, Xiang
    Yu, Lemao
    Wu, Yonghua
    Gao, Xiaozhong
    Cai, Tao
    Chen, Bin
    Shen, Runpu
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 174 : 159 - 180
  • [2] Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
    Peng, Yunhua
    Liu, Jing
    Inuzuka, Hiroyuki
    Wei, Wenyi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (04)
  • [3] Targeted protein knockdown using small molecule degraders
    Raina, Kanak
    Crews, Craig M.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2017, 39 : 46 - 53
  • [4] Small-Molecule Approaches to Targeted Protein Degradation
    Faust, Tyler B.
    Donovan, Katherine A.
    Yue, Hong
    Chamberlain, Philip P.
    Fischer, Eric S.
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 5, 2021, 2021, 5 : 181 - 201
  • [5] Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery
    Pei, Haixiang
    Peng, Yangrui
    Zhao, Qiuhua
    Chen, Yihua
    RSC ADVANCES, 2019, 9 (30): : 16967 - 16976
  • [6] Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
    An, Sainan
    Fu, Liwu
    EBIOMEDICINE, 2018, 36 : 553 - 562
  • [7] Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
    Arter, Chris
    Trask, Luke
    Ward, Sarah
    Yeoh, Sharon
    Bayliss, Richard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (08)
  • [8] Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development
    Tan, Xueqiang
    Huang, Zuyi
    Pei, Hairun
    Jia, Zongchao
    Zheng, Jimin
    ISCIENCE, 2024, 27 (09)